Expert Urges Companies to Heed Whistleblowers
This article was originally published in The Gray Sheet
Executive Summary
As device makers come under more scrutiny for fraud from the federal government, David Marshall, an attorney who specializes in whistleblower cases, says companies that deal with non-compliance issues early are much more likely to get lenient treatment than those who try covering them up.
You may also be interested in...
Stryker's OtisMed Pleads Guilty For Selling FDA-Rejected Cutting Guides
The unit and its former CEO admitted to selling knee-replacement instruments even after FDA rejected a 510(k), prior to OtisMed being acquired by Stryker in 2009. The legal resolution comes with about $80 million in fines and possible jail time for the former CEO. Also, Stryker has agreed to conduct an audit on the FDA approval status of devices in its portfolio.
Medtronic Settles False Claims Case For $9.9 Million
The company has resolved allegations from the Department of Justice to that it paid illegal kickbacks to doctors to implant Medtronic pacemakers and defibrillators.
News Briefs: Boston Sci Settlement; C.R. Bard Scores Patent Victory
Boston Scientific owes another $30 million to settle more charges related to Guidant ICD issues. C.R. Bard closer to receiving big payout from Gore on patent case. FDA issues a safety alert on St. Jude’s Amplatzer occluder More news briefs.